Advances in Substance Abuse and Addiction
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Pharmaceutical Science".
Deadline for manuscript submissions: 28 June 2024 | Viewed by 136
Special Issue Editors
2. Graduate Institute of Biomedical Sciences, China Medical University, Taichung 40402, Taiwan
Interests: addiction medicine; opioid pharmacology; cell biology; data analysis
2. School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan
3. Center for Neuropsychiatric Research, National Health Research Institute, Miaoli 350401, Taiwan
4. Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei 112304, Taiwan
Interests: psychiatry; schizophrenia; neurochemical and pharmacogenetic mechanisms
Special Issue Information
Dear Colleagues,
This Special Issue, entitled “Advances in Substance Abuse and Addiction”, aims to collate original research, reviews, and meta-analysis about the current challenges and solutions for substance use disorders (including nicotine, alcohol, illicit, and prescription drugs), providing a valuable resource for researchers, clinicians, and policy makers in the addiction medicine field. The scope of this Special Issue includes neurochemical and pharmacogenetic mechanisms related to addiction prevention, treatment, and recovery process, with a focus on translational research (from bench to bedside and vice versa). Topics to be considered involve in vitro and in vivo investigations of the pharmacological and behavioral actions of the substance of abuse, addiction treatment, and prevention research in humans. The goal is to identify the emerging trends and unmet needs of people with substance use disorders and serve as a platform to connect industrial and academic communities with regulatory agencies as well as treatment facilities in the field of addiction medicine.
We invite suggestions for manuscripts to be included in this Special Issue. Please contact the editors before preparing your manuscript for a pre-arrangement of the topic.
Dr. Cynthia Wei-Sheng Lee
Prof. Dr. Tsuo-Hung Lan
Dr. Chieh-Liang Huang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- addiction medicine
- opioid pharmacology
- substance abuse
- addictive disorders intervention
